-

OMNY Health Bolsters C-Suite, Hires New Chief Commercial Officer After Reaching One Billion Patient Encounters

The Leader in Democratizing Data Access Brings Aboard the Former Group Vice President of Life Sciences at Komodo Health

ATLANTA--(BUSINESS WIRE)--OMNY Health, the leading healthcare ecosystem known for facilitating compliant cross-industry data sharing, today announced the first expansion of its c-suite since 2021. Ivy Weng, MD, former Group Vice President of Life Sciences at Komodo Health, will join OMNY Health as its first Chief Commercial Officer following its most significant growth milestone yet: one billion patient encounters, which impact the care outcomes of millions of patients.

Weng will oversee OMNY Health’s commercial operations as it looks to scale, drive revenue growth, and elevate its market presence in life sciences, AI, medical devices, and clinical research organizations. ​​Weng’s extensive background in the life sciences sector includes leading enterprise multi-year software sale deals exceeding $50 million with the top 20 pharmaceutical companies. Her experience across areas such as commercial analytics, medical affairs, market access, RWE/HEOR, clinical development, and R&D will be instrumental in advancing OMNY Health’s development and implementation of commercial strategy.

“I’m excited to join OMNY Health and continue driving our mission of enhancing healthcare data connectivity and accessibility. OMNY’s platform uniquely connects providers with life sciences companies, creating a virtuous cycle that directly benefits both clinicians and patient outcomes,” said Weng. “OMNY is building the richest tapestry of representative patient encounters—and we’re just getting started.”

OMNY Health’s work with AI and life sciences partners, including QuantHealth and ArisGlobal, expedites drug development through simulated clinical trials and utilizes real-world evidence to predict clinical trial outcomes, drug efficacy, and patient responses. OMNY Health’s data also addresses disparities in pharma by closing significant demographic information gaps in drug discovery and development.

“We have merely scratched the surface of OMNY Health’s impact with our milestone of one billion patient encounters,” said Mitesh Rao, MD, Founder and CEO of OMNY Health. “Although we’ve seen tremendous growth since 2017, there remains a vast amount of work ahead in democratizing access to data and empowering life sciences, health systems, AI companies, and more to drive healthcare innovation. Appointing Ivy Weng to lead our commercial division was a clear decision—her leadership will be instrumental in advancing OMNY Health’s mission to enable deeper clinical research and impact the lives of millions more as we continue to expand.”

This news comes on the heels of the company’s GLP-1 Data Network, which supplies life sciences and health system partners, as well as its AI-driven health tech partners, with additional knowledge of GLP-1 use, related social determinants of health (SDOH) and patient demographics to better inform generative AI tools, researchers, and clinicians. To learn more about how OMNY Health transforms lives and drives patient care by connecting providers and life sciences companies through data, visit https://omnyhealth.com/.

About OMNY Health

OMNY Health™ is a national data ecosystem connecting the world of healthcare to fuel partnerships that improve clinical outcomes and drive patient care. OMNY Health’s dynamic partnerships with specialty health networks, healthcare systems, academic medical centers, and integrated delivery networks span all fifty states and cover over 75 million patient lives. The company’s comprehensive data layer powers health tech companies to drive the next generation of innovation. The platform serves as a centralized resource for life sciences and healthcare provider groups to facilitate mutually beneficial data sharing and research collaboration at scale, fueling innovation where patients need it the most. OMNY Health’s data ecosystem now reflects more than seven years of historical data encompassing more than 2 billion clinical notes from 300,000+ providers across 200+ specialties—and is growing. For more information, visit www.omnyhealth.com.

Contacts

OMNY Health
omny@solcomms.co

OMNY Health


Release Versions

Contacts

OMNY Health
omny@solcomms.co

More News From OMNY Health

OMNY Health Dataset Hits 100 Million Patient Milestone, Unlocking Unprecedented Access to Healthcare Data for Research

ATLANTA--(BUSINESS WIRE)--OMNY Health, the leading healthcare ecosystem for compliant real-world data (RWD) insights at scale, today announced its data network now officially encompasses insights from more than 100 million patients across all 50 U.S. states. This landmark achievement solidifies OMNY Health’s position as a premier source for comprehensive, HIPAA-compliant de-identified RWD, providing life sciences organizations, healthcare providers, and AI innovators with unparalleled access to...

OMNY Health Adds More Than 300 Health Measures to Enhance Disease Progression Research and Treatment Monitoring

ATLANTA--(BUSINESS WIRE)--OMNY Health, the leading healthcare ecosystem for compliant real-world data insights at scale, today announced it has expanded its data network by adding more than 300 clinical assessment measures. These disease-specific measures include information derived from clinical severity indicators, surveys, and questionnaires, such as the Crohn’s Disease Activity Index (CDAI) and the Harvey Bradshaw index for Gastroenterology, as well as the Asthma Control Test and COPD Asses...

OMNY Health Becomes the First EHR Dataset Available on Datavant Connect Powered by AWS Clean Rooms

ATLANTA--(BUSINESS WIRE)--OMNY Health, the leading healthcare ecosystem for compliant real-world data insights at scale, today announced it has become the first electronic health record (EHR) company to offer its real world data (RWD) dataset on Datavant Connect powered by AWS Clean Rooms through its Lighthouse Partner Program. This collaboration builds upon the success of OMNY Health and Datavant’s longstanding relationship to enhance clinical research and drug development. Traditionally, iden...
Back to Newsroom